OncoLens: Funding, Investors & Team (Oct 2026)
An AI driven oncology care platform that delivers next level multidisciplinary team collaboration, analytics and clinical decision support tools. The OncoLens platform: • Integrates patient data across disparate data systems including EMRs, genomics, PACS, pathology and more. • Extracts actionable informatics from structured and unstructured data to identify patients for clinical trials, biomarker testing, stem cell therapies and more. • Enables multi-disciplinary care team collaboration within and across enterprises.
OncoLens has raised $23.3M across 3 funding rounds on record, the most recent a Series B of $16.0M announced in Oct 2024.
That round is above the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
OncoLens Company Profile and Key Stats
Latest funding round on record: Oct 2024.
OncoLens Funding Rounds
1 of 3 rounds was announced without a disclosed amount and is excluded from the total.
OncoLens raised $7.3M in a Series A announced in Jan 2021.
2.5 years later, an undisclosed round was announced in Jul 2023 with no disclosed amount.
1.3 years later, a Series B of $16.0M was announced in Oct 2024.
OncoLens Founders and Leadership Team
Contact details for the OncoLens team: 2 of 2 have an email address on file.
Start 14-day free trial →OncoLens Funding Compared to Other Health Care Startups
OncoLens' latest round of $16.0M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like OncoLens in Health Care and Atlanta
Companies Similar to OncoLens
Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…
General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Aptatek is developing cutting edge technologies for portable disease management devices that will improve…
Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…
Light Wave Dental Management offers management services for high-quality dental offices in Virginia.…
For health care systems and payers focused on improving maternal outcomes and health equity, our product is a…
Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…
Vibronix was established by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University with the goal of offering…
People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…
OncoLens Funding FAQs
What does OncoLens do?
An AI driven oncology care platform that delivers next level multidisciplinary team collaboration, analytics and clinical decision support tools. The OncoLens platform: • Integrates patient data across disparate data systems including EMRs, genomics, PACS, pathology and more. • Extracts actionable informatics from structured and unstructured data to identify patients for clinical trials, biomarker testing, stem cell therapies and more. • Enables multi-disciplinary care team collaboration within and across enterprises.
How much funding has OncoLens raised?
OncoLens has raised $23.3M across 3 rounds on record. The most recent is a Series B of $16.0M announced in Oct 2024.
When did OncoLens last raise funding?
OncoLens' most recent funding round on record is a Series B of $16.0M, announced in Oct 2024.
Who founded OncoLens?
FundedIQ lists Lijo Simpson (Founder) at OncoLens.
Who is the CEO of OncoLens?
Anju Mathew is listed as CEO at OncoLens.
Where is OncoLens headquartered?
OncoLens is based in Atlanta, Georgia, United States.
How many employees does OncoLens have?
OncoLens is in the 1-10 employee band.
How does OncoLens' funding compare to other Health Care startups?
OncoLens' latest round of $16.0M is above the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's OncoLens Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for OncoLens is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.